Medication info
Zepazinduo Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)

Zepazinduo Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White, oval, double-sided, convex film-coated tablet with a yellow tint
Packaging
Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]
Approval status
Active

MFDS item code 202501740 · Approved 2025.07.10 · Insurance code 645406550

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2). Older patients In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Failure to control blood sugar
  • type 2 diabetes
  • cardiovascular disease
View approved original text

This medication helps adult patients with type 2 diabetes improve blood sugar control together with diet and exercise therapy. It is particularly effective in patients whose blood sugar is not adequately controlled, and can be used cautiously in the presence of cardiovascular diseases. This medication effectively lowers blood sugar through the actions of empagliflozin and metformin, aiding in diabetes management. When used safely under the guidance of a specialist according to the patient's condition, it can improve blood sugar control.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2). Older patients In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is used to help control blood sugar in diabetes patients. When using this medication, caution is necessary as rare side effects such as severe lactic acidosis may occur. Lactic acidosis can lead to serious conditions due to excessive accumulation of lactic acid in the body, which can be life-threatening. Furthermore, caution is needed as there is a risk of hypoglycemia when used with other diabetes medications such as insulin or sulfonylureas. This medication should not be used in patients with moderate to severe renal dysfunction or in those with acute renal problems. In patients with severe heart failure or acute heart issues, severe infections, or dehydration, taking this medication may pose risks and should be avoided. When undergoing examinations using radiographic iodine contrast agents, this medication should be discontinued for a certain period before and after the exam, and it should only be resumed after confirming normal kidney function. Pregnant women, women who may become pregnant, and nursing mothers should avoid taking this medication. This medication can increase urination, potentially causing fluid loss or blood pressure drop, so special caution should be exercised in the elderly or those at risk of dehydration. While taking this medication, vitamin B12 levels may decrease, so it is advisable to check through blood tests if necessary. Alcohol consumption may worsen the effects of this medication on lactic acid metabolism, so excessive drinking should be avoided while taking this medication. This medication may cause hypoglycemic symptoms, so further caution is needed when meals are skipped or exercise levels are high, and in case of hypoglycemic symptoms, immediate consultation with medical personnel is essential. While taking this medication, genital or urinary tract infections may occur, so related symptoms should be reported immediately. If surgery is planned, this medication should be discontinued 48 hours prior to the surgery, and it should be resumed only after confirming the recovery of normal kidney function. Elderly patients are at higher risk for kidney function decline, so regular monitoring of kidney function is necessary, and dosage adjustments may be needed. In case of overdose, severe side effects may occur, so it is crucial to adhere to the prescribed dosage, and if unusual symptoms arise, immediate medical attention should be sought. Finally, this medication is not to be used in children, as its safety and efficacy in this population have not been established. Lastly, this medication should be stored out of reach of children and kept in its original container to maintain quality.

Side effects

Hypoglycemia, urinary tract infection, genital infection, increased urination, decreased and deficiency of vitamin B12, ketoacidosis, lactic acidosis, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, hives, erythema, angioedema, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, perineal necrosis, vulvovaginitis, balanitis, fluid loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), chronic gastritis, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, tendinitis, facial bone fracture, musculoskeletal pain, myocardial infarction, pancreatic adenocarcinoma, constipation, gastritis, oral discomfort, salivary gland pain, headache, dizziness, asthenia, chest discomfort, chest pain, fever, facial swelling, chills, strange sensations, edema, pain, vascular stent stenosis, vascular stent thrombosis, increased alanine aminotransferase, increased aspartate aminotransferase, weight loss, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, diplopia, hypertension, insomnia, epistaxis, asthma, exertional dyspnea, productive cough, allergic rhinitis, otalgia, positional vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, diabetic foot, dermoid cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, ocular discomfort, conjunctival hyperemia, pathological myopia, retinal detachment, retinal deposits, retinal vein occlusion, traction retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, cough, dyspnea, angina, palpitations, Prinzmetal angina, coronary artery disease, atherosclerosis, deep vein thrombosis, diabetic vascular disorders, peripheral artery occlusive disease, anxiety, depression, sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. This way, the medication's effectiveness is maintained for a longer duration and can be used safely.

Appearance and packaging

Appearance

White, oval, double-sided, convex film-coated tablet with a yellow tint

Package unit

Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.